Print

BrainStorm Cell Therapeutics Inc. Announces Pricing of Underwritten Public Offering  
8/13/2013 10:08:38 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK & PETAH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) today announced the pricing of a $4.0 million underwritten public offering of 23,529,411 units at a public offering price of $0.17 per unit, with each unit consisting of one share of its common stock, par value $0.00005 per share, and 0.75 of a warrant to purchase one share of its common stock at an exercise price of $0.25 per share. The offering is expected to close on August 16, 2013 subject to customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

//-->